This study defines a core outcome set (COS), that is a widely accepted standard set of outcomes, for quality of life (QOL) in a population of adults with drug-resistant epilepsy.
Why this matters
Epilepsy is characterized by recurrent seizures that have a deleterious effect on QOL.
Currently, there is no COS defined to improve QOL for people living with drug-resistant epilepsy.
Considering this proposed COS in future trials will allow for meaningful results and consistency in measurement and reporting that can be extended to clinical practice.